National Hereditary Breast and Ovarian Cancer Week
By: Courtney Floyd
This week marks the beginning of National Hereditary Breast and Ovarian Cancer Week! Additionally, Wednesday, September 30th is Previvor Day! This week is dedicated to those affected by hereditary breast or ovarian cancer, including women and men with BRCA mutations, family history of cancers, and survivors!
The BRCA gene test is a blood test designed to identify harmful DNA mutations in either one of the two breast cancer predisposition genes (BRCA1 or BRCA2). Although it is believed everyone has these genes, mutations in the gene can cause a significantly increased risk for developing breast cancer. While breast cancer can be caused by numerous variables, many women find the BRCA tests to be empowering, giving them the opportunity to take a proactive step against breast cancer.
For eligible patients, PRMA surgeons offer the option of prophylactic mastectomy with immediate breast reconstruction to help reduce the chance of breast cancer. Although the risk of breast cancer can never be completely removed, preventative surgery does greatly reduce the chances. To learn more about the breast reconstruction options offered at PRMA click here.
"With a well-executed mastectomy and reconstruction – especially an autologous reconstruction – the BRCA patient can have a very positive outcome, in which breast cancer risk is greatly reduced, and the size, shape and consistency of the breasts approaches normal," says PRMA surgeon Dr. Steven Pisano.
The goal of HBOC Week and Previvor Day is to raise awareness about hereditary cancer. HBOC Week marks the shift between National Ovarian Cancer Awareness Month and National Breast Cancer Awareness Month.